Dawei Rong
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 8
- Oncology 10
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Weiwei Tang (27 shared papers)Xuehao Wang (13 shared papers)Hongyong Cao (12 shared papers)Betty Zhang (3 shared papers)Kai Fu (7 shared papers)Handong Sun (3 shared papers)Fan Wu (5 shared papers)Wenling Zhang (2 shared papers)
In The Last Decade
Dawei Rong
40 papers receiving 3.3k citations
Dawei Rong's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 1.3k
- Hepatology 248
- Molecular Biology 1.9k
- Immunology 437
- Oncology 508
Countries citing papers authored by Dawei Rong
This map shows the geographic impact of Dawei Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Rong more than expected).
Fields of papers citing papers by Dawei Rong
This network shows the impact of papers produced by Dawei Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Rong. The network helps show where Dawei Rong may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Rong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects Hit paper breakdown → | 2020 | 842 |
| 2 | 2017 | 414 | |
| 3 | 2019 | 343 | |
| 4 | Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing Hit paper breakdown → | 2022 | 232 |
| 5 | 2018 | 211 | |
| 6 | 2017 | 134 | |
| 7 | 2021 | 115 | |
| 8 | 2021 | 81 | |
| 9 | 2022 | 78 | |
| 10 | 2022 | 74 | |
| 11 | 2021 | 72 | |
| 12 | 2021 | 72 | |
| 13 | 2021 | 71 | |
| 14 | 2022 | 62 | |
| 15 | 2017 | 51 | |
| 16 | 2019 | 44 | |
| 17 | 2020 | 41 | |
| 18 | 2023 | 40 | |
| 19 | 2019 | 35 | |
| 20 | 2022 | 34 |
About Dawei Rong
Dawei Rong is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Surgery, having authored 40 papers that have together received 3.3k indexed citations. Recurring topics across this work include Circular RNAs in diseases (11 papers), Cancer-related molecular mechanisms research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), MicroRNA in disease regulation (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Immune cells in cancer (5 papers), Immune Cell Function and Interaction (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Hepatology (248 citations), Molecular Biology (1.9k citations), Immunology (437 citations) and Oncology (508 citations). Dawei Rong has collaborated with scholars based in China, Germany and Canada. Frequent co-authors include Weiwei Tang, Xuehao Wang, Hongyong Cao, Betty Zhang, Kai Fu, Handong Sun, Fan Wu, Wenling Zhang, Ye Cheng and Zhouxiao Li. Their work appears in journals such as Cancer Biomarkers, Frontiers in Cell and Developmental Biology, International Journal of Biological Sciences, Annals of Translational Medicine and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.